343 related articles for article (PubMed ID: 33472824)
21. Role of dopamine D3 receptor in alleviating behavioural deficits in animal models of post-traumatic stress disorder.
Song D; Ge Y; Chen Z; Shang C; Guo Y; Zhao T; Li Y; Wu N; Song R; Li J
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):190-200. PubMed ID: 29510167
[TBL] [Abstract][Full Text] [Related]
22. Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research.
Papini S; Sullivan GM; Hien DA; Shvil E; Neria Y
Biol Psychol; 2015 Jan; 104():8-18. PubMed ID: 25448242
[TBL] [Abstract][Full Text] [Related]
23. A cross species study of heterogeneity in fear extinction learning in relation to FKBP5 variation and expression: Implications for the acute treatment of posttraumatic stress disorder.
Galatzer-Levy IR; Andero R; Sawamura T; Jovanovic T; Papini S; Ressler KJ; Norrholm SD
Neuropharmacology; 2017 Apr; 116():188-195. PubMed ID: 28025095
[TBL] [Abstract][Full Text] [Related]
24. Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD.
Andero R; Brothers SP; Jovanovic T; Chen YT; Salah-Uddin H; Cameron M; Bannister TD; Almli L; Stevens JS; Bradley B; Binder EB; Wahlestedt C; Ressler KJ
Sci Transl Med; 2013 Jun; 5(188):188ra73. PubMed ID: 23740899
[TBL] [Abstract][Full Text] [Related]
25. Time-dependent protective effects of morphine against behavioral and morphological deficits in an animal model of posttraumatic stress disorder.
RaiseAbdullahi P; Vafaei AA; Ghanbari A; Dadkhah M; Rashidy-Pour A
Behav Brain Res; 2019 May; 364():19-28. PubMed ID: 30753875
[TBL] [Abstract][Full Text] [Related]
26. Single prolonged stress: toward an animal model of posttraumatic stress disorder.
Yamamoto S; Morinobu S; Takei S; Fuchikami M; Matsuki A; Yamawaki S; Liberzon I
Depress Anxiety; 2009; 26(12):1110-7. PubMed ID: 19918929
[TBL] [Abstract][Full Text] [Related]
27. Inhibiting corticosterone synthesis during fear memory formation exacerbates cued fear extinction memory deficits within the single prolonged stress model.
Keller SM; Schreiber WB; Stanfield BR; Knox D
Behav Brain Res; 2015; 287():182-6. PubMed ID: 25839906
[TBL] [Abstract][Full Text] [Related]
28. Fear extinction induced by activation of PKA ameliorates anxiety-like behavior in PTSD mice.
Gao F; Wang J; Yang S; Ji M; Zhu G
Neuropharmacology; 2023 Jan; 222():109306. PubMed ID: 36341808
[TBL] [Abstract][Full Text] [Related]
29. A novel approach to PTSD modeling in rats reveals alternating patterns of limbic activity in different types of stress reaction.
Ritov G; Boltyansky B; Richter-Levin G
Mol Psychiatry; 2016 May; 21(5):630-41. PubMed ID: 26552592
[TBL] [Abstract][Full Text] [Related]
30. Effects of vagus nerve stimulation on extinction of conditioned fear and post-traumatic stress disorder symptoms in rats.
Noble LJ; Gonzalez IJ; Meruva VB; Callahan KA; Belfort BD; Ramanathan KR; Meyers E; Kilgard MP; Rennaker RL; McIntyre CK
Transl Psychiatry; 2017 Aug; 7(8):e1217. PubMed ID: 28892066
[TBL] [Abstract][Full Text] [Related]
31. Nicotine-Derived Compounds as Therapeutic Tools Against Post-Traumatic Stress Disorder.
Barreto GE; Yarkov A; Avila-Rodriguez M; Aliev G; Echeverria V
Curr Pharm Des; 2015; 21(25):3589-95. PubMed ID: 26166610
[TBL] [Abstract][Full Text] [Related]
32. The downside of strong emotional memories: how human memory-related genes influence the risk for posttraumatic stress disorder--a selective review.
Wilker S; Elbert T; Kolassa IT
Neurobiol Learn Mem; 2014 Jul; 112():75-86. PubMed ID: 24012801
[TBL] [Abstract][Full Text] [Related]
33. On the Road to Translation for PTSD Treatment: Theoretical and Practical Considerations of the Use of Human Models of Conditioned Fear for Drug Development.
Risbrough VB; Glenn DE; Baker DG
Curr Top Behav Neurosci; 2016; 28():173-96. PubMed ID: 27311760
[TBL] [Abstract][Full Text] [Related]
34. Glycyrrhizin treatment ameliorates post-traumatic stress disorder-like behaviours and restores circadian oscillation of intracranial serotonin.
Lai S; Shi L; Jiang Z; Lin Z
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):95-101. PubMed ID: 31494960
[TBL] [Abstract][Full Text] [Related]
35. Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats.
Morena M; Berardi A; Colucci P; Palmery M; Trezza V; Hill MN; Campolongo P
Neuropsychopharmacology; 2018 May; 43(6):1284-1296. PubMed ID: 29265107
[TBL] [Abstract][Full Text] [Related]
36. Neuropeptide Y, resilience, and PTSD therapeutics.
Kautz M; Charney DS; Murrough JW
Neurosci Lett; 2017 May; 649():164-169. PubMed ID: 27913193
[TBL] [Abstract][Full Text] [Related]
37. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia.
Etkin A; Wager TD
Am J Psychiatry; 2007 Oct; 164(10):1476-88. PubMed ID: 17898336
[TBL] [Abstract][Full Text] [Related]
38. Functional Neuroanatomy of Emotion and Its Regulation in PTSD.
Fitzgerald JM; DiGangi JA; Phan KL
Harv Rev Psychiatry; 2018; 26(3):116-128. PubMed ID: 29734226
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity to trauma-associated cues is restricted to vulnerable traumatized rats and reinstated after extinction by yohimbine.
Le Dorze C; Gisquet-Verrier P
Behav Brain Res; 2016 Oct; 313():120-134. PubMed ID: 27392642
[TBL] [Abstract][Full Text] [Related]
40. Revisiting propranolol and PTSD: Memory erasure or extinction enhancement?
Giustino TF; Fitzgerald PJ; Maren S
Neurobiol Learn Mem; 2016 Apr; 130():26-33. PubMed ID: 26808441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
